FDA inspection
Guardian Drug Co. Inc.: FDA inspection ending Jan 16, 2026
FDA inspection 1304382 · No Action Indicated (NAI) · Dayton, NJ
Key facts
| Inspection ID | 1304382 |
|---|---|
| Firm | Guardian Drug Co. Inc. |
| FEI number | 2245306 |
| Address | 2 Charles Ct |
| City | Dayton |
| State | NJ |
| ZIP | 08810 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jan 16, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data